CD163 and pachyonychia congenita: We confirmed that Siglec-9 is co-expressed with CD14+ (a myeloid marker) (Fig. 5b and Supplementary Fig. 5c) and CD163+ (alternatively activated macrophage marker) (Fig. 5c and Supplementary Fig. 5c) in PC patient biopsies.